Microplastics and nanoplastics have emerged as a previously unrecognized but increasingly relevant source of chronic environmental exposure. Once thought to be biologically inert, these particles—derived from degraded consumer plastics and industrial materials—are now routinely detected in human blood, stool, lung tissue, placenta, breast milk, and even atherosclerotic plaques. Their presence in these tissues challenges long-standing assumptions about plastic safety and raise